A private investment firm with offices in New York City and in Asia is investing from a US$180 million fund into the healthcare sector. Typical equity investments range from US$5-10 million in businesses from Series A to pre-IPO and public traded companies. The firm is opening to leading or following a syndicated round. The firm is now seeking opportunities in North America.
The firm invests across therapeutics, medical devices, diagnostics, platform technologies, and healthcare IT and is looking for companies that are top 3 in their niche sector. Within therapeutics, the firm prefer clinical stage projects. The firm is opportunistic in terms of disease areas including orphan indications. Within device and diagnostics, the firm prefers post-prototype products with clinical validation.
The firm may request board representation or board observership on a case-by-case basis.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org